S1400626
ABC600mg+3TC300mg tabs/PAC-30 gb
Abacavir Sulfate 600mg + Lamivudine 300mg film coated tablets, bottle pack of 30. (gb = generic / bottle)
Indicative Price 6.60 USD
General Description
Abacavir Sulfate equivalent to 600mg Abacavir + Lamivudine 300mg film coated tablets, bottle pack of 30
(gb = generic / bottle)
Technical Specifications
Each film coated tablet contains Abacavir Sulfate equivalent to 600mg Abacavir plus Lamivudine 300mg.
Tablets should be scored with at least one break line to allow for division of tablets into two parts, each containing the same amount of active ingredients.
Pack comes with Warning Card
Therapeutic class
Abacavir and Lamivudine are nucleoside reverse transcriptase inhibitors (NRTI).
Standard shelf life
2 Years (24 Months)
Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.
Guidelines for use
For more details, please see WHO treatment guidelines http://www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library http://www.who.int/emlib/ or your regional/national guidelines.
Indications
Management of HIV infection in adults in combination with at least one other antiretroviral drug. By mouth (oral) PO.
Storage
Do not store above 30° (86ºF).
Store in tightly closed original container
Keep out of reach and sight of children
Dispensing instructions
Dispense in original container. Do not repack
Pack comes with Warning Card
Can be taken without regard to food
Regulatory Status
For latest updates check the list of ‘Prequalified Medicines’ on the WHO website ‘Prequalification Programme’. http://apps.who.int/prequal/
For latest updates check the list of ‘USFDA approved and tentatively approved’ items on the USFDA website. http://www.fda.gov/default.htm, http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/
Related Products




